Life Chemicals is proud to sponsor the upcoming International Helmholtz Drug Discovery Conference (HDDC2025) on April 28–30, 2025, in Berlin, Germany.
We are also happy to exhibit at this high-profile symposium that will bring together global experts to discuss cutting-edge developments in RNA drug targets, novel cardiovascular therapeutics, PROTACs, and Artificial Intelligence in drug discovery.
The Company representative, Anna Prömmer, will showcase our latest collections and innovations for Early Drug Discovery, including:
-
Proprietary HTS Compound Collection: 575,000 original drug-like compounds, all available in stock
-
RNA Screening Libraries comprising more than 29,000 drug-like small-molecule compounds with predicted RNA-binding activity
-
Cardiovascular Focused Library featuring over 9,000 drug-like small molecules with predicted activity against clinically relevant cardiovascular targets
-
Degrader Building Blocks: compounds for targeted protein degradation, including predicted E3 ligase binders and linker-like structures
-
Novel Generative AI Designed Target Selective Compounds, developed in collaboration with Variational AI
-
Welcome to our booth
-
Schedule a meeting with Anna Prömmer, CEO of Life Chemicals Europe, in advance! It will give you a remarkable opportunity to find products and solutions that will accelerate your drug discovery programs.
Contact:
Anna Prömmer, MSc
CEO, Life Chemicals Europe
Anna.Proemmer@lifechemicals-eu.com
+49(0)1738154426